Related Experiment Videos

Management of chronic functional constipation in childhood

Adrian Plunkett1, Claire P Phillips, R Mark Beattie

  • 1Paediatric Medical Unit, Southampton General Hospital, Southampton, UK.

Paediatric Drugs
|February 13, 2007
PubMed

Insights

Childhood constipation requires early diagnosis and holistic care, often starting with non-drug treatments and stimulant laxatives. More research is needed to establish evidence-based guidelines for effective pediatric constipation management.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Clinical Medicine

Background:

  • Chronic functional constipation is a prevalent childhood issue, often complicated by soiling.
  • Current drug treatments for pediatric constipation have a weak evidence base, leading to varied clinical practices.
  • Effective management hinges on early diagnosis, prompt intervention, and holistic care.

Purpose of the Study:

  • To highlight the complexities and challenges in managing chronic functional constipation in children.
  • To emphasize the need for evidence-based guidelines and further research in pediatric constipation treatment.

Main Methods:

  • Review of current clinical practices and evidence base for childhood constipation.
  • Description of a practical, non-drug-focused approach incorporating patient education and behavioral modification.
  • Use of stimulant laxatives as first-line therapy in high doses.

Main Results:

  • Significant variability exists in treatment approaches across different healthcare units.
  • A notable lack of robust evidence supports commonly used drug treatments for childhood constipation.
  • Holistic care and non-drug interventions are crucial for successful management.

Conclusions:

  • There is an urgent need for prospective comparative and longitudinal studies to evaluate treatment efficacy and long-term outcomes.
  • The paucity of data challenges the development of evidence-based guidelines for pediatric constipation.
  • Multidisciplinary support and patient education are vital components of successful management strategies.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...